Contrasting Dynatronics (NASDAQ:DYNT) & Atrion (NASDAQ:ATRI)

Dynatronics (NASDAQ:DYNT) and Atrion (NASDAQ:ATRI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, earnings, institutional ownership and profitability.

Analyst Recommendations

This is a breakdown of current recommendations for Dynatronics and Atrion, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dynatronics 0 0 3 0 3.00
Atrion 0 0 0 0 N/A

Dynatronics currently has a consensus price target of $3.88, indicating a potential upside of 120.17%. Given Dynatronics’ higher probable upside, analysts clearly believe Dynatronics is more favorable than Atrion.

Risk & Volatility

Dynatronics has a beta of 0.03, indicating that its stock price is 97% less volatile than the S&P 500. Comparatively, Atrion has a beta of 0.33, indicating that its stock price is 67% less volatile than the S&P 500.

Dividends

Atrion pays an annual dividend of $5.40 per share and has a dividend yield of 0.7%. Dynatronics does not pay a dividend. Atrion has raised its dividend for 16 consecutive years.

Institutional and Insider Ownership

13.0% of Dynatronics shares are owned by institutional investors. Comparatively, 62.6% of Atrion shares are owned by institutional investors. 44.0% of Dynatronics shares are owned by insiders. Comparatively, 22.1% of Atrion shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Dynatronics and Atrion’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Dynatronics -1.92% -12.65% -3.05%
Atrion 22.76% 16.89% 15.30%

Earnings & Valuation

This table compares Dynatronics and Atrion’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Dynatronics $64.42 million 0.23 -$1.60 million ($0.40) -4.40
Atrion $152.45 million 9.54 $34.26 million N/A N/A

Atrion has higher revenue and earnings than Dynatronics.

Summary

Atrion beats Dynatronics on 11 of the 14 factors compared between the two stocks.

About Dynatronics

Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products. The company also provides electrotherapy, ultrasound, phototherapy, and thermal therapy modalities; motorized and stationary treatment tables and mat platforms; custom athletic training equipment; and strength and cardio training equipment. In addition, it distributes a range of products, such as exercise equipment, treatment tables, treadmills, walkers, compression therapy devices, stair climbers, parallel bars, laser light therapy equipment, shortwave diathermy, and radial pulse equipment. The company sells its products to licensed practitioners, such as orthopedists, physical therapists, chiropractors, and athletic trainers, professional sports teams and universities, sports medicine specialists, post-acute care facilities, hospitals and clinics, retail distributors and equipment manufacturer partners through direct and independent sales representatives and independent dealers. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Cottonwood Heights, Utah.

About Atrion

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 Myocardial Protection System that delivers fluids and medications, mixes critical drugs, and controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.